抑肝散活性成分治疗阿尔茨海默病伴发抑郁障碍的网络药理学研究  

Network pharmacological analysis on the active ingredients of Yigan Powder in treating Alzheimer's disease with depressive disorder

作　　者：赵驰 郭蓉娟[2] 任非非 于姚 李俊男 李阳 ZHAO Chi;GUO Rong-juan;REN Fei-fei;YU Yao;LI Jun-nan;LI Yang(Beijing University of Chinese Medicine,Beijing 100029,China;Dongfang Hospital,Beijing University of Chinese Medicine,Beijing 100078,China;Beijing Hospital of Traditional Chinese Medicine,Beijing 100010,China)

机构地区：[1]北京中医药大学,北京100029 [2]北京中医药大学东方医院,北京100078 [3]首都医科大学附属北京中医医院,北京100010

出　　处：《海南医学院学报》2022年第2期124-134,共11页Journal of Hainan Medical University

基　　金：国家自然科学基金面上项目(81874422);北京中医药大学优秀传承团队—王永炎名医传承工作站建设项目(1000062720028/010)。

摘　　要：目的:通过网络药理学方法,研究抑肝散治疗阿尔茨海默病伴发抑郁障碍的可能药效机制。方法:通过中药系统药力学分析平台(TCMSP)筛选中药活性成分,通过Swiss Target Prediction数据库进行反向靶点预测,通过GeneCards、OMIM及PharmGKB数据库收集疾病靶标,利用R语言对交集基因进行GO功能富集分析和KEGG通路富集分析,通过String数据库获取蛋白相互作用数据,运用Cytoscape软件进行成分、靶点网络分析及可视化,使用AutoDock Vina及PyMOL软件进行分子对接。结果:经筛选得到抑肝散活性成分125种,预测靶点953个,85个靶点与阿尔茨海默病伴发抑郁相关,抑肝散的药效作用靶点与阿尔茨海默病及抑郁症的多个信号通路和生物学过程高度富集,PPI网络结果显示APP、MAPK1、STAT3等靶蛋白可能是抑肝散治疗阿尔茨海默病伴发抑郁的重要作用靶点。分子对接结果表明,抑肝散活性成分与重要靶点结合活性较好。结论:抑肝散治疗阿尔茨海默病伴发抑郁具有多成分-多靶点-多通路的作用特点,可以通过改善神经递质代谢、调节神经突触传递、减轻神经炎症等多个方面治疗阿尔茨海默病伴发抑郁障碍。Objective:To study the potential therapeutic effect of Yigan Powder on Alzheimer's disease with depressive disorder using network pharmacology method.Methods:The active ingredients of Yigan Powder were screened from Traditional Chinese Medicine Systems Pharmacology database and analysis platform,and targets were predicted by Swiss Target Prediction database.Disease targets were collected from GeneCards,OMIM and PharmGKB databases.GO function enrichment and KEGG pathway enrichment analyses were performed using R language.Moreover,protein-protein interaction(PPI)data were obtained from the String database and Cytoscape software was used to build network of ingredients and targets.Molecular docking was done by AutoDock Vina and PyMOL software.Results:There were 125 active ingredients in Yigan Powder with 953 predicted tar-gets,85 of which were related to Alzheimer's disease with depressive disorder,showing highly enriched signaling pathways and bi-ological processes.PPI network analysis showed APP,MAPK1 and STAT3 may be important potential targets for treating Al-zheimer's disease with depressive disorder.In addition,the results of molecular docking showed that the active ingredients of Yigan Powder had good binding activity with important targets.Conclusion:Yigan Powder can be used in the treatment of Al-zheimer's disease with depressive disorder by improving neurotransmitter metabolism and synaptic transmission,and alleviating neuroinflammation.

关 键 词：抑肝散 阿尔茨海默病 抑郁障碍 网络药理学 

分 类 号：R285.5[医药卫生—中药学]